There were no significant losers this week which is a rare treat.
JLP:Jubilee Metals is on a real march, with everything coming together and anticipation of an announcement of maiden profit possibly as soon as next week. The shares climbed 5% and my holding is now only 1% down and losing just £51. I'm glad I hung on in there, as this may end up making me some money. I have 104,545 shares, so if we move from increments of 0.1p to increments of 1p then each penny is worth £1,000 and would be the equivalent of OPTI:Optibiotix in the magnitude of rises and falls.
My IQE:IQE holding is around the same size as my JLP:Jubilee Metals holding in terms of cost, so a climb of 7% was excellent this week. All their customers are announcing excellent results, so that should filter down to profits. Add to that the new foundry significantly improving capacity for production, and we may get back over 100p. My ISA holding is only 1% in the red now, but my SIPP is still 44% down.
Share of the Week is SBTX:SkinBioTherapeutics which climbed 13% and I feel a bit bad that I celebrated this by selling a load on Friday. My remaining ISA holding is still down, but by only 4% now.
There are so many shares on the cusp of getting back into profit. If next week is kind then there could be more green on my spreadsheet than I've seen for a few years.
A dip in cost following the sale, as I've not re-invested yet. Value plus cash creeps up a bit.
Moving in the right direction. Can it last?
Here's the ISA and share portfolios
| Weekly Change | |||
| Cash | £23.24 | +£20.00 | |
| Portfolio cost | £57,768.95 | +£0 | |
| Portfolio sell value (bid price-commission) | £46,607.85 | (-19.3%) | +£1,160.32 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£58.05 | (-1.2%) | +£4.84 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £418.98 | (8.7%) | -£1.90 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 13.5% | +0% | |
| Compound performance | 57% | +0% |
I added £20 cash as there wasn't enough in the account to cover the ISA charges. I could do with selling something to get my year 5 profit in the black. The loss was incurred when I sold AMYT:Amryt Pharma because Harry Stratford stepped down as Chair. They are now selling for 117p as opposed to the 100p I got, so I would have made £68 profit instead of £165 loss. However, I wouldn't have been able to buy a load of OPTI:Optibiotix shares at 46.7p which are up 35% which is worth £480. Only problem is I've vowed never to sell any OPTI:Optibiotix shares because I want the dividend to be my retirement income. 5% of my target share price of £6 in 5 years time is dividend of 30p a share. That would give me £30,000 tax free income a year, which would be nice!
I have two new metrics!
I realised that I've been very tough on myself with my average monthly performance figures as I'm basing them on the cost of the portfolio. As the cost increases with re-investment, it gets increasingly difficult to hit the 10% target. I still want to keep that target, but for ease of mind I've added another percentage based on the injection amount, which doesn't go up when profits are re-invested. That's showing an average of 13.5% per month. I feel a lot better now!
The other new metric is a straightforward compound performance based on total profit plus dividends minus fees divided by the total injection amount. 57% is a nice return for just over 4 years. I suppose you could still work that out by multiplying 13.5 by 4 and a bit, but it's nice to see it spelled out.
Slow and steady.
Dragging that trend line flatter!
Here's the SIPP after week 205
| Weekly Change | ||||
| Cash | £3,437.97 | +£3,231.80 | ||
| Portfolio cost | £41,575.85 | -£2,389.57 | ||
| Portfolio sell value (bid price - commission) |
£35,790.85 | (-13.9%) | +£66.97 | |
| Potential profits | £407.97 | -£400.68 | ||
| Yr 4 Dividends | £556.99 | +£0 | ||
| Yr 4 Interest | £0.10 | +£0 | ||
| Yr 4 Profit from sales | £2,004.18 | +£842.23 | ||
| Yr 4 Average monthly cash profit | £213.59 | (6.2%) | +£71.59 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.13 | +£0 | ||
| Total Profit from sales | £12,549.10 | +£842.23 | ||
| Average monthly cash profit | £296.37 | (8.6%) | +£16.44 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 12.8% | +0.8% | ||
| Compound performance | 50% | +3% |
A complex picture this week. Cash is up from the proceeds of the SBTX:SkinBioTherapeutics sale. I sold all my 16,983 shares at 19.1p after paying 14p which gave £842 (35%) profit. I bought these in the fire sale after taking a small loss on CAML:Central Asia Metals because I couldn't bear to see them so cheap. In theory I should put the proceeds back into CAML because I want to get it up to 10% of my portfolio. However, I think traders are playing around with SBTX like they have been with OPTI, and 20p has proved a resistance point several times before. I'm going to do what I've never managed before and keep the cash in anticipation of a SBTX dip. My target to buy back in is 16p. If the anticipated news comes in and the price rockets, I still have my ISA holding and a vast holding courtesy of my OPTI shares so I'm hoping it's a sound strategy. Having said that, if there is news of a big deal next week I may howl quite loudly.
Although the sell value has come down a lot, if you take into account the cost also reducing, then the rest of the portfolio is up by £66 this week. Profits are down by £400 due to the sale, but as that yielded £842 then potential profits would have been up £442 this week, all of which was SBTX.
Year 4 performance has been enhanced greatly from projected average of 4% a month to 6.2% and my long-term average improved by 0.6% from 8% to 8.6% which I really needed to do as I was way off target.Looking at the new metrics, the performance based on the injection amount went up by 0.8% to 12.8% and the compound performance went up 3% from 47% to 50%.
Quite a nice way to narrow the gap, but it will widen again when the cash vanishes and the cost goes back up.
I had to overhaul these performance charts as I realised I was including cash in the value. This chart had a big rise for this week which was completely wrong. Most of the time it doesn't matter as there's very little cash in the account, but it was really obvious this week. Now this is only including the shares value, whereas cash is still included on the top chart.
Here's the trading account after week 171
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,375.48 | (-40.7%) | +£17.46 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £3.81 | (2.0%) | -£0.28 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.41 | (-0.2%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
Small rises for a few of the stocks but a quiet week really. The new measures are very similar to the ones based on cost as the cost and injection are almost identical. The plan is for the injection to reduce in this one as I withdraw profits. That might make the figures meaningless, especially if it goes below £0 but that's a long way off based on current performance.
Creeping up but still a way off selling anything. CAML:Central Asia Metals is only 17% down so that's the most likely candidate, although IQE:IQE can move very quickly when it wants, but has 31% to make up.
Still looking better, but a long way in the red.
That's all for this week. I can't wait for next week as there's all sorts of things could be happening with JLP:Jubilee Metals, IQE:IQE, SBTX:SkinBioTherapeutics and OPTI:Optibiotix, and I have a big pile of cash should any opportunities arise. I hope the opportunity is to buy back into SBTX, but if that rockets I'll still be happy and spend it on something else - possibly £2,500 back into CAML:Central Asia Metals where it was robbed from in the first place, and £900 on something exciting.
No comments:
Post a Comment